Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
HL don't currently offer the bed & ISA I believe.
Best thing would be to place the equivalent funds into a stock and shares and purchase and then sell in your investment account. May lose a few shares/quid
Investors that lose money use the SP as confirmation to buy or sell.
Investors that make money pay no attention to the SP, merely the fundamentals.
If you've done the research that is widely available on Google, you would have averaged down greatly on the false drop to 200 and be sitting very comfortable now.
'All existing non-disclosure agreements interested parties have already signed with the Company in relation to the potential acquisition of the Monchetundra asset remain valid.'
Suggests there are already interested parties in place for Monch but almost a come and take the whole thing off our hands plea to others.
Exciting times.
Very simple and revealed in the General Update. Corporate governance procedures were being reviewed and updated in these 3 months.
Now they are on the verge of being finalised which will be confirmed by the signature of the new Nomad.
Wow that poster from ADVFN seems to be one of the most knowledgeable looking through his history. I am very concerned now. Think I will sell on Monday morning.
If only I listened earlier :(
'There are too many people infected to make testing an effective means of controlling an outbreak during a pandemic. The horse has already bolted. What will bring this pandemic under control is exactly what world governments are doing which is to enforce lock down and isolation'
'Contrary to what people think it's not about accuracy but about time. A 5 minute test with a 95% accuracy is preferable to a 2 hour test with a 100% accuracy.'
'There's no evidence that anything is or has ever been sold in commercial quantities. Scour all the media websites and outlets to find a single article or picture that says or shows a batch of Primerdesign test kits has been delivered.'
In the coming months Novacyt will have to advise the market of how they plan to capitalise on their test sales. This will then decide whether the company can sustain a high market cap.
AVCT on paper has more strings to its bow on paper.
Pumped like crazy on twitter. Talks of £1.50 and all sorts.
A good solid company with lots of upside but don't get caught in the spike